Proactiveinvestors USA & Canada Kazia Therapeutics Ltd https://www.proactiveinvestors.com Proactiveinvestors USA & Canada Kazia Therapeutics Ltd RSS feed en Thu, 22 Aug 2019 04:40:07 -0400 http://blogs.law.harvard.edu/tech/rss Genera CMS action@proactiveinvestors.com (Proactiveinvestors) action@proactiveinvestors.com (Proactiveinvestors) <![CDATA[News - Kazia Therapeutics concludes recruitment into Part B of its phase I ovarian cancer clinical study ]]> https://www.proactiveinvestors.com/companies/news/900577/kazia-therapeutics-concludes-recruitment-into-part-b-of-its-phase-i-ovarian-cancer-clinical-study-900577.html Tue, 13 Aug 2019 11:19:00 -0400 https://www.proactiveinvestors.com/companies/news/900577/kazia-therapeutics-concludes-recruitment-into-part-b-of-its-phase-i-ovarian-cancer-clinical-study-900577.html <![CDATA[News - Kazia Therapeutics to begin phase I clinical trial for cancer that has spread to the brain ]]> https://www.proactiveinvestors.com/companies/news/224237/kazia-therapeutics-to-begin-phase-i-clinical-trial-for-cancer-that-has-spread-to-the-brain-224237.html Mon, 22 Jul 2019 11:29:00 -0400 https://www.proactiveinvestors.com/companies/news/224237/kazia-therapeutics-to-begin-phase-i-clinical-trial-for-cancer-that-has-spread-to-the-brain-224237.html <![CDATA[News - Kazia Therapeutics substantial holder Willoughby Capital increases interest to 17.52% ]]> https://www.proactiveinvestors.com/companies/news/223644/kazia-therapeutics-substantial-holder-willoughby-capital-increases-interest-to-1752-223644.html Wed, 10 Jul 2019 02:26:00 -0400 https://www.proactiveinvestors.com/companies/news/223644/kazia-therapeutics-substantial-holder-willoughby-capital-increases-interest-to-1752-223644.html <![CDATA[News - Kazia Therapeutics substantial shareholder lifts interest to 17.4% ]]> https://www.proactiveinvestors.com/companies/news/223348/kazia-therapeutics-substantial-shareholder-lifts-interest-to-174-223348.html Thu, 04 Jul 2019 18:13:00 -0400 https://www.proactiveinvestors.com/companies/news/223348/kazia-therapeutics-substantial-shareholder-lifts-interest-to-174-223348.html <![CDATA[News - Kazia Therapeutics has two novel classes of anti-cancer drugs: Edison Investment Research ]]> https://www.proactiveinvestors.com/companies/news/223001/kazia-therapeutics-has-two-novel-classes-of-anti-cancer-drugs-edison-investment-research-223001.html Fri, 28 Jun 2019 12:34:00 -0400 https://www.proactiveinvestors.com/companies/news/223001/kazia-therapeutics-has-two-novel-classes-of-anti-cancer-drugs-edison-investment-research-223001.html <![CDATA[News - Kazia Therapeutics to collaborate with US-based oncology foundation on clinical trials for metastatic brain cancer treatment ]]> https://www.proactiveinvestors.com/companies/news/220551/kazia-therapeutics-to-collaborate-with-us-based-oncology-foundation-on-clinical-trials-for-metastatic-brain-cancer-treatment-220551.html Sun, 19 May 2019 22:45:00 -0400 https://www.proactiveinvestors.com/companies/news/220551/kazia-therapeutics-to-collaborate-with-us-based-oncology-foundation-on-clinical-trials-for-metastatic-brain-cancer-treatment-220551.html <![CDATA[News - Kazia Therapeutics gains new substantial holder in The Bank of New York Mellon ]]> https://www.proactiveinvestors.com/companies/news/219839/kazia-therapeutics-gains-new-substantial-holder-in-the-bank-of-new-york-mellon-219839.html Wed, 08 May 2019 14:56:00 -0400 https://www.proactiveinvestors.com/companies/news/219839/kazia-therapeutics-gains-new-substantial-holder-in-the-bank-of-new-york-mellon-219839.html <![CDATA[News - Kazia Therapeutics releases new safety data to assist in brain cancer treatments ]]> https://www.proactiveinvestors.com/companies/news/313249/kazia-therapeutics-releases-new-safety-data-to-assist-in-brain-cancer-treatments-13249.html Tue, 07 May 2019 21:02:00 -0400 https://www.proactiveinvestors.com/companies/news/313249/kazia-therapeutics-releases-new-safety-data-to-assist-in-brain-cancer-treatments-13249.html <![CDATA[News - Kazia Therapeutics' ongoing study confirms higher drug tolerability in newly-diagnosed glioblastoma patients ]]> https://www.proactiveinvestors.com/companies/news/219706/kazia-therapeutics--ongoing-study-confirms-higher-drug-tolerability-in-newly-diagnosed-glioblastoma-patients-219706.html Mon, 06 May 2019 00:20:00 -0400 https://www.proactiveinvestors.com/companies/news/219706/kazia-therapeutics--ongoing-study-confirms-higher-drug-tolerability-in-newly-diagnosed-glioblastoma-patients-219706.html <![CDATA[News - Kazia Therapeutics studies evaluate therapeutic candidates in ovarian cancer and brain tumours ]]> https://www.proactiveinvestors.com/companies/news/219425/kazia-therapeutics-studies-evaluate-therapeutic-candidates-in-ovarian-cancer-and-brain-tumours-219425.html Wed, 01 May 2019 18:30:00 -0400 https://www.proactiveinvestors.com/companies/news/219425/kazia-therapeutics-studies-evaluate-therapeutic-candidates-in-ovarian-cancer-and-brain-tumours-219425.html <![CDATA[News - Kazia Therapeutics to present positive ovarian cancer drug data at AACR annual meeting ]]> https://www.proactiveinvestors.com/companies/news/312814/kazia-therapeutics-to-present-positive-ovarian-cancer-drug-data-at-aacr-annual-meeting-12814.html Mon, 01 Apr 2019 22:45:00 -0400 https://www.proactiveinvestors.com/companies/news/312814/kazia-therapeutics-to-present-positive-ovarian-cancer-drug-data-at-aacr-annual-meeting-12814.html <![CDATA[News - Kazia Therapeutics will outline anti-cancer drug development strategy at CEO Sessions ]]> https://www.proactiveinvestors.com/companies/news/214129/kazia-therapeutics-will-outline-anti-cancer-drug-development-strategy-at-ceo-sessions-214129.html Thu, 07 Feb 2019 11:35:00 -0500 https://www.proactiveinvestors.com/companies/news/214129/kazia-therapeutics-will-outline-anti-cancer-drug-development-strategy-at-ceo-sessions-214129.html <![CDATA[News - Kazia Therapeutics developing unique drug to battle brain cancer ]]> https://www.proactiveinvestors.com/companies/news/311805/kazia-therapeutics-developing-unique-drug-to-battle-brain-cancer-11805.html Fri, 11 Jan 2019 10:17:00 -0500 https://www.proactiveinvestors.com/companies/news/311805/kazia-therapeutics-developing-unique-drug-to-battle-brain-cancer-11805.html <![CDATA[News - Kazia Therapeutics progresses phase II clinical trial for brain cancer drug ]]> https://www.proactiveinvestors.com/companies/news/193977/kazia-therapeutics-progresses-phase-ii-clinical-trial-for-brain-cancer-drug-193977.html Thu, 29 Mar 2018 08:28:00 -0400 https://www.proactiveinvestors.com/companies/news/193977/kazia-therapeutics-progresses-phase-ii-clinical-trial-for-brain-cancer-drug-193977.html